Researchers have identified networks of misplaced immune cells, particularly plasma cells, driving idiopathic pulmonary fibrosis (IPF), a fatal lung disease. These cells, typically found in bone ...

Scientists found that aggressive lung cancer cells create their own electrical network, helping them spread. This unique ...

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...

Small-cell lung cancer (SCLC) is the most aggressive type of lung cancer. Each year in the U.S., about 30,000 to 35,000 people are diagnosed with it. For most, it has already spread to distant ...

Feb. 12, 2025 — Researchers have found that some particularly aggressive lung cancer cells can develop their own electric network, like that seen in the body's nervous ... Feb. 6, 2025 ...

Using real world data from 1,600 patients, available ... Mar. 13, 2025 — A discovery about how severe COVID-19 damages lung cells suggests that an existing drug could treat lingering respiratory ...

Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting ...

Lung cancer often goes undetected until it’s too late. But a new urine test developed by Cambridge scientists could change that.

Positive preliminary data from the phase 1b/2 trial evaluating Olvi-Vec in small cell lung cancer have been announced.

Johnson & Johnson has produced the most convincing data to date that its combination of Rybrevant and Lazcluze could replace ...

Report commissioned by govt analysed cost-effectiveness of 2 medicines, comparing them to to chemo in patients with newly ...

The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced ...